Birzeit Pharmaceuticals Company (PEX: BPC)

Market Cap	106.25M
Revenue (ttm)	26.88M
Net Income (ttm)	2.53M
Shares Out	38.76M
EPS (ttm)	0.07
PE Ratio	41.24
Forward PE	n/a
Dividend	0.04 (1.25%)
Ex-Dividend Date	Apr 24, 2024

Volume	23,000
Average Volume	19,659
Open	3.990
Previous Close	n/a
Day's Range	3.990 - 3.990
52-Week Range	n/a
Beta	0.02
RSI	53.19
Earnings Date	Feb 13, 2025

About PEX: BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an...

• Industry: Pharmaceutical Preparations
• Founded: 1973
• Employees: 300
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: BPC

Financial Performance

In 2023, BPC's revenue was $43.13 million, a decrease of -8.31% compared to the previous year's $47.03 million. Earnings were $6.12 million, a decrease of -23.05%.

Financial numbers in USD